Deutsche Bank plans capped return enhanced notes linked to biotech ETF

By Angela McDaniels

Tacoma, Wash., Sept. 27 – Deutsche Bank AG, London Branch plans to price 0% capped return enhanced notes due Oct. 17, 2018 linked to the iShares Nasdaq Biotechnology exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.

If the final share price is greater than the initial share price, the payout at maturity will be par plus two times the stock return, subject to a maximum return that will be at least 20.4% and will be set at pricing. If the final share price is less than the initial share price, investors will be exposed to the decline.

JPMorgan Chase Bank, NA and J.P. Morgan Securities LLC are the agents.

The notes will price Sept. 29.

The Cusip number is 25155MEF4.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.